With FDA verging on its first COVID booster approval, Pfizer and Moderna will have to recalibrate revenues—again
TrustVaccines
via FiercePharma: Vaccines https://ift.tt/2zKtXvv
August 12, 2021 at 11:34AM
With FDA verging on its first COVID booster approval, Pfizer and Moderna will have to recalibrate revenues—again
Welcome to vaccine education 